These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4353792)

  • 1. Differential sensitivity of virulent and attenuated strains of type 1 poliovirus to polyethylene glycol as a possible new genetic marker.
    Lokteva VF; Chumakov MP; Zhevandrova VI; Shekoyan LA
    Arch Gesamte Virusforsch; 1973; 41(3):155-9. PubMed ID: 4353792
    [No Abstract]   [Full Text] [Related]  

  • 2. A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine.
    Vonka V; Janda Z; Simon J; Adam E; Stárek M
    Prog Med Virol; 1967; 9():204-55. PubMed ID: 4293687
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential sensitivity to gliotoxin of virulent and attenuated poliovirus strains and its possible use as a genetic marker.
    Sergiescu D; Aubert-Combiescu A
    Arch Gesamte Virusforsch; 1969; 27(2):268-81. PubMed ID: 4313025
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies of genetic markers of poliovirus strains].
    Yamawaki S
    Kumamoto Igakkai Zasshi; 1970 Dec; 44(12):1165-208. PubMed ID: 4325315
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic changes in attenuated poliovirus strains cultivated on human intestine in vitro.
    Fogel A; Plotkin SA
    Am J Epidemiol; 1968 Mar; 87(2):385-95. PubMed ID: 4296726
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible selection of virulent poliovirus strains in Third-World countries.
    Metselaar D
    Lancet; 1976 Jan; 1(7952):174-6. PubMed ID: 54685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.
    van Wezel AL; Hazendonk AG
    Intervirology; 1979; 11(1):2-8. PubMed ID: 218891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratypic serodifferentiation of poliovirus type 1 strains isolated during outbreaks of paralytic poliomyelitis.
    Deshpande JM; Dave KH
    Indian J Med Res; 1988 Feb; 87():103-7. PubMed ID: 2840388
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to poliovirus diagnosis using laboratory techniques: memorandum from a WHO meeting.
    Bull World Health Organ; 1992; 70(1):27-33. PubMed ID: 1348972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.
    Macadam AJ; Ferguson G; Stone DM; Meredith J; Knowlson S; Auda G; Almond JW; Minor PD
    J Virol; 2006 Sep; 80(17):8653-63. PubMed ID: 16912313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).
    Tagaya I; Nakao C; Hara M; Yamadera S
    Bull World Health Organ; 1973 May; 48(5):547-54. PubMed ID: 4359681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV; Sokolova IS; Alpatova GA
    Arch Gesamte Virusforsch; 1971; 33(3):259-70. PubMed ID: 4329636
    [No Abstract]   [Full Text] [Related]  

  • 13. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poliomyelitis situation in Madagascar in 1993. Several considerations about the role of the laboratory in the eradication strategy].
    Morvan JM
    Arch Inst Pasteur Madagascar; 1993; 60(1-2):14-9. PubMed ID: 7910726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poliomyelitis associated with type-2 poliovirus vaccine strain. Possible transmission from an immunised child to a non-immunised child.
    Stolley PD; Joseph JM; Allen JC; Deane G; Janney JH
    Lancet; 1968 Mar; 1(7544):661-3. PubMed ID: 4170650
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution and polymorphism of poliovirus genomes.
    Crainic R; Kew O
    Biologicals; 1993 Dec; 21(4):379-84. PubMed ID: 8024754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
    Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
    Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of poliovirus towards dextran sulphate and relationship between this character and other genetic markers.
    Sergiescu D; Horodniceanu F; Crainic R
    Arch Roum Pathol Exp Microbiol; 1967 Jun; 26(2):453-63. PubMed ID: 4298003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.